In conclusion, this study demonstrates that artesunate has the potential to modulate the malignant progression of breast cancer cells through the lncRNA TUG1/miR-145-5p/HOXA5 axis, offering promising evidence for its anti-cancer effects. This evidence concerns the gene HOXA5 and breast carcinoma.